CIK 0001022079 · Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161387862
- Phone
- 9735202700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- 4 Planned sale SVP for Diagnostic Services sold 11,717 shares at $257.34 ($3,015,253)
- 4 Grant or award SVP, Regional Businesses acquired 352 shares (grant or award)
- 4 Planned sale Executive Vice President sold 22,105 shares at an average $248.02 ($5,482,442)
- 4 Grant or award SVP & Chief Commercial Officer acquired 2,615 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 1,203 shares at $243.00 ($292,329)
- 4 Other acquisition Director acquired 10 shares (code L)
- 4 Grant or award Executive Vice President & CFO acquired 90 shares (grant or award)
- 4 Grant or award Director acquired 63 shares (grant or award)
- 4 Other acquisition SVP, Clinical Solutions acquired 33 shares (code L)
- 4 Other acquisition Director acquired 6 shares (code L)
- 4 Other acquisition SVP for Diagnostic Services acquired 41 shares (code L)
- 4 Other acquisition Director acquired 18 shares (code L)
- 4 Other acquisition SVP & Chief Commercial Officer acquired 25 shares (code L)
- 4 Derivatives Options or other derivatives
- 4 Planned sale CEO and President sold 10,000 shares at $242.72 ($2,427,200)
- 4 Planned sale SVP & General Counsel sold 22,677 shares at an average $243.11 ($5,513,083)
- 4 Planned sale SVP & Chief Commercial Officer sold 1,600 shares at $235.18 ($376,288)
- 4 Other acquisition SVP, Clinical Solutions acquired 37 shares (code L)
- 4 Other acquisition Director acquired 11 shares (code L)
Page 1 of 74 · 1,465 filings